Becton, Dickinson and Company BDX Interventional — Cost of products sold

Other segment segments

Similar metrics at other companies

TWINManufacturing — Intersegment Cost Of Goods Sold

-$11.44M+13.6%

ROKIntelligent Devices — Cost of Product and Service Sold

$533M+10.6%

TWINManufacturing — Intrasegment Cost Of Goods Sold

-$2.02M-2.3%

JNJInnovative Medicine — Cost of products sold

$4.39B+9.2%

MDTMedical Surgical — Cost of products sold, excluding amortization of intangible assets

$964M+10.8%

JNJMedTech — Cost of products sold

$3.7B+11.3%

Questions, answered.

What is Becton, Dickinson and Company's interventional — cost of products sold?

Becton, Dickinson and Company (BDX) reported interventional — cost of products sold of $429M in Q1 2026.

How has Becton, Dickinson and Company's interventional — cost of products sold changed year-over-year?

Becton, Dickinson and Company's interventional — cost of products sold increased by 7.0% year-over-year, from $401M to $429M.

What does interventional — cost of products sold mean?

This metric captures the direct costs associated with manufacturing and delivering the products sold within the Interventional segment. It includes raw materials, direct labor, and manufacturing overhead directly attributable to these specific medical devices.